Keeping them separate

Should all S2 and S3 medicines to be kept behind the counter, with a completely separate area for CMs? And who supports this proposition? Recently the Review of Pharmacy Remuneration and Regulation released its interim report, and submissions to the report have begun flowing in over the past few weeks. One contentious suggestion by the

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Alternative medicine doubles risk of cancer death
Next Hitting the ballots